Stay updated on Tisagenlecleucel in HR B-ALL Clinical Trial

Sign up to get notified when there's something new on the Tisagenlecleucel in HR B-ALL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tisagenlecleucel in HR B-ALL Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now shows an updated list of study locations with new sites in Indianapolis, IN (Indiana University) and Rome, Italy, and a reduced total of 43 locations.
    Difference
    0.8%
    Check dated 2026-06-08T04:52:09.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The website version is updated from v3.5.3 to v3.5.4, indicating an under-the-hood update to the platform. No study text or data were changed on the page.
    Difference
    0.0%
    Check dated 2026-05-18T03:30:27.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    A new citation has been added to Publications for an immunotherapy article by Davis et al., with full bibliographic details. This adds additional reference material for readers.
    Difference
    0.0%
    Check dated 2026-05-11T01:48:50.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The study page text did not change; the content described in the provided page context remains the same, including the study overview, eligibility criteria, and listed locations.
    Difference
    0.0%
    Check dated 2026-05-04T01:01:30.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The page’s displayed interface revision was updated from v3.5.2 to v3.5.3, indicating a non-content system/version change rather than a change to the clinical trial information.
    Difference
    0.1%
    Check dated 2026-04-26T15:21:51.000Z thumbnail image
  8. Check
    54 days ago
    Change Detected
    Summary
    Expanded Access record added and availability noted outside the clinical trial; new locations Calgary, Canada and Roma, Italy are listed with updated address formatting, and the revision version updated to v3.5.2 (replacing the prior v3.5.0 entries).
    Difference
    0.5%
    Check dated 2026-04-19T13:35:48.000Z thumbnail image

Stay in the know with updates to Tisagenlecleucel in HR B-ALL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tisagenlecleucel in HR B-ALL Clinical Trial page.